Year |
Citation |
Score |
2018 |
Solomon IH, Li H, Benson LA, Henderson LA, Degar BA, Gorman MP, Duncan CN, Lidov HG, Alexandrescu S. Histopathologic Correlates of Familial Hemophagocytic Lymphohistiocytosis Isolated to the Central Nervous System. Journal of Neuropathology and Experimental Neurology. PMID 30295794 DOI: 10.1093/Jnen/Nly094 |
0.308 |
|
2018 |
Li H, Natarajan A, Ezike J, Barrasa MI, Yang H, Ma C, Markoulaki S, Lodish H. Single Cell Resolution of Glucocorticoid Effects on Erythroid Progenitor Cells Blood. 132: 751-751. DOI: 10.1182/Blood-2018-99-112445 |
0.306 |
|
2017 |
Pishesha N, Bilate AM, Wibowo MC, Huang NJ, Li Z, Dhesycka R, Bousbaine D, Li H, Patterson HC, Dougan SK, Maruyama T, Lodish HF, Ploegh HL. Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America. PMID 28270614 DOI: 10.1073/Pnas.1701746114 |
0.357 |
|
2016 |
Li H, Shi J, Huang NJ, Pishesha N, Natarajan A, Eng JC, Lodish HF. Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells. Haematologica. PMID 26969085 DOI: 10.3324/Haematol.2015.135723 |
0.345 |
|
2014 |
Wu TL, Li H, Faust SM, Chi E, Zhou S, Wright F, High KA, Ertl HC. CD8+ T cell recognition of epitopes within the capsid of adeno-associated virus 8-based gene transfer vectors depends on vectors' genome. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 42-51. PMID 24077034 DOI: 10.1038/Mt.2013.218 |
0.557 |
|
2014 |
Li H, Shi J, Lodish HF. Genome Editing in Erythroid Progenitor Cells Mediated By Crispr/Cas9 Blood. 124: 1345-1345. DOI: 10.1182/Blood.V124.21.1345.1345 |
0.458 |
|
2013 |
Anguela XM, Sharma R, Doyon Y, Miller JC, Li H, Haurigot V, Rohde ME, Wong SY, Davidson RJ, Zhou S, Gregory PD, Holmes MC, High KA. Robust ZFN-mediated genome editing in adult hemophilic mice. Blood. 122: 3283-7. PMID 24085764 DOI: 10.1182/Blood-2013-04-497354 |
0.578 |
|
2013 |
Parzych EM, Li H, Yin X, Liu Q, Wu TL, Podsakoff GM, High KA, Levine MH, Ertl HC. Effects of immunosuppression on circulating adeno-associated virus capsid-specific T cells in humans. Human Gene Therapy. 24: 431-42. PMID 23461589 DOI: 10.1089/Hum.2012.246 |
0.515 |
|
2012 |
Wu T, Töpfer K, Lin SW, Li H, Bian A, Zhou XY, High KA, Ertl HC. Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome. Molecular Therapy : the Journal of the American Society of Gene Therapy. 20: 572-9. PMID 22186792 DOI: 10.1038/Mt.2011.280 |
0.525 |
|
2012 |
Anguela XM, Sharma R, Doyon Y, Wong SY, Paschon DE, Li H, Haurigot V, Davidson RJ, Zhou S, Gregory PD, Holmes MC, Rebar E, High KA. In Vivo Genome Editing of Liver Albumin for Therapeutic Gene Expression: Rescue of Hemophilic Mice Via Integration of Factor 9 Blood. 120: 751-751. DOI: 10.1182/Blood.V120.21.751.751 |
0.589 |
|
2011 |
Li H, Haurigot V, Doyon Y, Li T, Wong SY, Bhagwat AS, Malani N, Anguela XM, Sharma R, Ivanciu L, Murphy SL, Finn JD, Khazi FR, Zhou S, Paschon DE, et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature. 475: 217-21. PMID 21706032 DOI: 10.1038/Nature10177 |
0.563 |
|
2011 |
Li H, Lasaro MO, Jia B, Lin SW, Haut LH, High KA, Ertl HC. Capsid-specific T-cell responses to natural infections with adeno-associated viruses in humans differ from those of nonhuman primates. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 2021-30. PMID 21587208 DOI: 10.1038/Mt.2011.81 |
0.53 |
|
2011 |
Li H, Tuyishime S, Wu TL, Giles-Davis W, Zhou D, Xiao W, High KA, Ertl HC. Adeno-associated virus vectors serotype 2 induce prolonged proliferation of capsid-specific CD8+ T cells in mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 536-46. PMID 21157435 DOI: 10.1038/Mt.2010.267 |
0.506 |
|
2011 |
Li H, Malani N, Hamilton SR, Schlachterman A, Bussadori G, Edmonson SE, Shah R, Arruda VR, Mingozzi F, Wright JF, Bushman FD, High KA. Assessing the potential for AAV vector genotoxicity in a murine model. Blood. 117: 3311-9. PMID 21106988 DOI: 10.1182/Blood-2010-08-302729 |
0.576 |
|
2011 |
Anguela XM, Sharma R, Li H, Haurigot V, Bhagwat A, Davidson RJ, Zhou S, Doyon Y, Gregory PD, Holmes MC, High KA. Robust Factor IX Expression Following ZFN-Mediated Genome Editing in An Adult Mouse Model of Hemophilia B Blood. 118: 668-668. DOI: 10.1182/Blood.V118.21.668.668 |
0.571 |
|
2010 |
Li H, Haurigot V, Doyon Y, Li J, Bhagwat A, Wong S, Anguela X, Sharma R, Ivanciu L, Murphy S, Zhou S, Paschon D, Rebar E, Gregory PD, Holmes MC, et al. Phenotypic Correction of a Mouse Model of Hemophilia B by In Vivo Genetic Correction of the F9 Gene Blood. 116: LBA-5-LBA-5. DOI: 10.1182/Blood.V116.21.Lba-5.Lba-5 |
0.59 |
|
2009 |
Li H, Lin SW, Giles-Davis W, Li Y, Zhou D, Xiang ZQ, High KA, Ertl HC. A preclinical animal model to assess the effect of pre-existing immunity on AAV-mediated gene transfer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 1215-24. PMID 19367258 DOI: 10.1038/Mt.2009.79 |
0.55 |
|
2009 |
Murphy SL, Li H, Mingozzi F, Sabatino DE, Hui DJ, Edmonson SA, High KA. Diverse IgG subclass responses to adeno-associated virus infection and vector administration. Journal of Medical Virology. 81: 65-74. PMID 19031458 DOI: 10.1002/Jmv.21360 |
0.499 |
|
2009 |
Li H, Malani N, Hamilton SR, Schlachterman A, Zhang JZ, Bussadori G, Edmonson SA, Mingozzi F, Wright JF, Arruda VR, Bushman FD, High KA. Assessment of Insertional Mutagenesis Risk Following AAV Vector-Mediated Factor IX Gene Transfer in Mice. Blood. 114: 2465-2465. DOI: 10.1182/Blood.V114.22.2465.2465 |
0.551 |
|
2008 |
Murphy SL, Li H, Zhou S, Schlachterman A, High K. Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 138-145. PMID 28192706 DOI: 10.1038/sj.mt.6300334 |
0.366 |
|
2008 |
Murphy SL, Li H, Zhou S, Schlachterman A, High KA. Corrigendum to "Prolonged Susceptibility to Antibody-mediated Neutralization for Adeno-associated Vectors Targeted to the Liver". Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 633. PMID 28178504 DOI: 10.1038/Sj.Mt.6300386 |
0.521 |
|
2008 |
Murphy SL, Li H, Zhou S, Schlachterman A, High KA, High K. Prolonged susceptibility to antibody-mediated neutralization for adeno-associated vectors targeted to the liver. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 138-45. PMID 17955024 DOI: 10.1038/Sj.Mt.6300334 |
0.582 |
|
2007 |
Li H, Murphy SL, Giles-Davis W, Edmonson S, Xiang Z, Li Y, Lasaro MO, High KA, Ertl HC. Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 792-800. PMID 17245353 DOI: 10.1038/Sj.Mt.6300090 |
0.554 |
|
Show low-probability matches. |